HomeInsightsStock Comparison

Aarti Drugs Ltd vs Coral Laboratories Ltd Stock Comparison

Aarti Drugs Ltd vs Coral Laboratories Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Aarti Drugs Ltd is ₹ 489.4 as of 01 Aug 15:30.
  • The P/E Ratio of Aarti Drugs Ltd changed from 8.3 on March 2020 to 23.3 on March 2024 . This represents a CAGR of 22.93% over 5 yearsThe P/E Ratio of Coral Laboratories Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Aarti Drugs Ltd changed from ₹ 1178 crore on March 2020 to ₹ 3988 crore on March 2024 . This represents a CAGR of 27.61% over 5 yearsThe Market Cap of Coral Laboratories Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Aarti Drugs Ltd for the Jun '25 is ₹ 590.82 crore as compare to the Mar '25 revenue of ₹ 678.63 crore. This represent the decline of -12.94% The revenue of Coral Laboratories Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Aarti Drugs Ltd for the Jun '25 is ₹ 74.39 crore as compare to the Mar '25 ebitda of ₹ 95.2 crore. This represent the decline of -21.86% The ebitda of Coral Laboratories Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Aarti Drugs Ltd changed from ₹ 47.97 crore to ₹ 53.97 crore over 9 quarters. This represents a CAGR of 5.38% The net profit of Coral Laboratories Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Aarti Drugs Ltd changed from 3.43 % on March 2020 to 6.48 % on March 2024 . This represents a CAGR of 13.57% over 5 yearsThe Dividend Payout of Coral Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aarti Drugs Ltd

  • Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals.
  • The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million.
  • With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs.
  • It has a wholly-owned subsidiary called Pinnacle Life Science Private Limited which operates in the field of manufacturing formulations. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra.
  • It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary).

About Coral Laboratories Ltd

  • Coral Laboratories Limited (CLL) was established in February, 1997.
  • Carol Labs are into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines.
  • The Company produces various pharmaceutical formulations in 3 different locations all over India.
  • It has plants at Daman and Dehradun . The Company was promoted by Navin B Doshi of the DWD group.
  • To manufacture pharmaceutical formulations like tablets, capsules, liquid and topical preparation, the Company went into public issue in March 94 at a total cost of Rs.2.5 crores.

Aarti Drugs Ltd News Hub

News

Aarti Drugs rises after Q1 PAT jumps 62% YoY to Rs 54 cr

Profit before tax (PBT) rose 16.2% YoY to Rs 51.11 crore in Q1 June 2025. EBITDA jumped 12...

Read more

21 Jul 2025 14:06

News

Aarti Drugs to convene board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 18 July 2025. ...

Read more

16 Jul 2025 10:24

News

Aarti Drugs to convene board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 6 May 2025. Po...

Read more

30 Apr 2025 11:38

News

Aarti Drugs receives affirmation in credit ratings from ICRA

Aarti Drugs has received reaffirmation in credit rating at ICRA AA-; Stable/ ICRA A1+ for ...

Read more

31 Jan 2025 19:10

News

Aarti Drugs gains as PAT rises to Rs 37 cr in Q3; declares dividend of Re 1/sh

Revenue from operations declined 6.44% to Rs 568.50 crore in third quarter of FY25 as comp...

Read more

30 Jan 2025 12:14

News

Board of Aarti Drugs recommends Interim Dividend

Aarti Drugs announced that the Board of Directors of the Company at its meeting held on 29...

Read more

29 Jan 2025 17:03

Coral Laboratories Ltd News Hub

News

Board of Coral Laboratories recommends final dividend

Coral Laboratories announced that the Board of Directors of the Company at its meeting hel...

Read more

31 May 2025 14:48

News

Coral Laboratories schedules board meeting

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 30 May ...

Read more

23 May 2025 20:23

News

Coral Laboratories announces board meeting date

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 13 Febr...

Read more

06 Feb 2025 13:39

News

Coral Laboratories schedules board meeting

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 14 Nove...

Read more

08 Nov 2024 17:38

News

Coral Laboratories announces board meeting date

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 24 Sept...

Read more

20 Sep 2024 10:20

News

Coral Laboratories to hold AGM

Coral Laboratories announced that the Annual General Meeting (AGM) of the company will be ...

Read more

20 Aug 2024 16:23

SWOT Analysis Of Coral Laboratories Ltd

Strength

3

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Aarti Drugs Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Coral Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Aarti Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aarti Drugs Ltd and Coral Laboratories Ltd

Which company has a larger market capitalization, Aarti Drugs Ltd or Coral Laboratories Ltd?

Market cap of Aarti Drugs Ltd is 4,499 Cr while Market cap of Coral Laboratories Ltd is 205 Cr

What are the key factors driving the stock performance of Aarti Drugs Ltd and Coral Laboratories Ltd?

The stock performance of Aarti Drugs Ltd and Coral Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarti Drugs Ltd and Coral Laboratories Ltd?

As of August 2, 2025, the Aarti Drugs Ltd stock price is INR ₹489.4. On the other hand, Coral Laboratories Ltd stock price is INR ₹574.7.

How do dividend payouts of Aarti Drugs Ltd and Coral Laboratories Ltd compare?

To compare the dividend payouts of Aarti Drugs Ltd and Coral Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions